TCR diversity – a universal cancer immunotherapy biomarker?

Overview of attention for article published in Journal for Immunotherapy of Cancer, November 2016

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (65th percentile)
Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter: 1 tweeter

patent: 1 patent

Citations

dimensions_citation: 17 Dimensions

Readers on

mendeley: 77 Mendeley

Summary Twitter Patents Dimensions citations

So far, Dimensions has found 17 publications that cite this research output.

17

The most recent citing publications are shown below. View all 17 publications that cite this research output on Dimensions.

Cancer neoantigens as potential targets for immunotherapy

Article in Clinical & Experimental Metastasis (May 2021)

Immune infiltrate diversity confers a good prognosis in follicular lymphoma

Article in Cancer Immunology, Immunotherapy (April 2021)

From Tumor Mutational Burden to Blood T Cell Receptor: Looking for the Best Predictive Biomarker in Lung Cancer Treated with Immunotherapy

Article in Cancers (October 2020)

This page shows the most recent citations of this research output.

Click here to find out how to access more activity.